Alyssum Therapeutics

Manufacturing · Massachusetts, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

626 Massachusetts Ave Fl 2, Cambridge, M...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Alyssum Therapeutics

Alyssum Therapeutics is focused on developing innovative drugs that transform the treatment of complex diseases, particularly through targeted immunotherapy. The company specializes in modulating B cells, which play a crucial role in immunity and have shown potential in improving survival outcomes in various tumors. Their lead molecule, AT1965, is currently in clinical trials for treating solid cancers, utilizing a unique mechanism that combines targeted therapy with immune response modulation. With a strong pipeline and a patented platform, Alyssum aims to enhance the efficacy and safety of its therapeutic offerings.Explore more
SIC Code 28,283NAICS Code 32,325Show more

Alyssum Therapeutics Org Chart

PhoneEmail
AB
United States flag for contact location.

Lead, Clinical Operations

PhoneEmail
Paul Theunissen, Chief Financial Officer at Alyssum Therapeutics
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
TA
United States flag for contact location.

Chief Development Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Alyssum Therapeutics

Compare insights from companies similar to Alyssum Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Alyssum Therapeutics

<$5M
11-50
Private
$26.5M
-
AB
Aditya BardiaLead, Clinical Operations
<$5M
11-50
Private
-
-
KH
Kwun HoSenior Manager
<$5M
11-50
Private
-
2022
CS
Camil SayeghChief Scientific Officer
<$5M
11-50
Private
$55M
2023
Jack Sadowsky, Co-founder and Vice President, Discovery Chemistry at Kimia
Jack SadowskyCo-founder and Vice President, Discovery Chemistry
Illustration of an envelope

Alyssum Therapeutics Tech Stack

A closer look at the technologies used by Alyssum Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Alyssum Therapeutics

What is Alyssum Therapeutics's official website?
Alyssum Therapeutics's official website is www.alyssumtx.com
What is Alyssum Therapeutics's Revenue?
Alyssum Therapeutics's revenue is <$5 Million
What is Alyssum Therapeutics's SIC code?
Alyssum Therapeutics's SIC: 28,283
What is Alyssum Therapeutics's NAICS code?
Alyssum Therapeutics's NAICS: 32,325
How many employees does Alyssum Therapeutics have?
Alyssum Therapeutics has 11-50 employees
What industry does Alyssum Therapeutics belong to?
Alyssum Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Alyssum Therapeutics competition?
Alyssum Therapeutics top competitors include: Psivant Therapeutics, Kimia, Sapu Bioscience
What technology does Alyssum Therapeutics use?
Some of the popular technologies that Alyssum Therapeutics uses are: Squarespace Online Stores, Squarespace
Who is the CFO of Alyssum Therapeutics?
Alyssum Therapeutics's CFO is Paul Theunissen
What does Alyssum Therapeutics do?

Alyssum Therapeutics is focused on developing innovative drugs that transform the treatment of complex diseases, particularly through targeted immunotherapy. The company specializes in modulating B cells, which play a crucial role in immunity and have shown potential in improving survival outcomes in various tumors. Their lead molecule, AT1965, is... currently in clinical trials for treating solid cancers, utilizing a unique mechanism that combines targeted therapy with immune response modulation. With a strong pipeline and a patented platform, Alyssum aims to enhance the efficacy and safety of its therapeutic offerings.Read More

Who invested in Alyssum Therapeutics?
Alyssum Therapeutics has 3 investors including Accel, Navam Capital and Famy.
Is Alyssum Therapeutics a public company?
Alyssum Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Alyssum Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.